3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 2/3
1
Status
Completed
4
Unknown
2
Terminated
2
Recruiting
2
Active not recruiting
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
2
Sponsor
Cancer Type
Tumor-Agnostic
1
Breast
1
Conditions
Colorectal Neoplasms
6
Stomach Neoplasms
3
Pain, Postoperative
3
Breast Neoplasms
3
Neurotoxicity Syndromes
2
Neoplasms
2
Nasopharyngeal Carcinoma
2
Multiple Endocrine Neoplasia Type 1
2
Lung Neoplasms
2
Delirium
2
Colonic Neoplasms
2
Warts
1
Ventilator-Induced Lung Injury
1
Thoracic Neoplasms
1
Spondylitis, Ankylosing
1
Spinal Cord Neoplasms
1
Skin Diseases
1
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Postoperative Complications
1
Pleural Effusion, Malignant
1
Pituitary Neoplasms
1
Pituitary Diseases
1
Peripheral Nervous System Diseases
1
Pathologic Complete Response
1
Ovarian Neoplasms
1
Neoplasms by Site
1
Meningioma
1
Lymphoma, Follicular
1
Interventions
Exercise
19
Drug Therapy
18
pembrolizumab
13
Capecitabine
11
Blood Specimen Collection
11
Surveys and Questionnaires
10
Radiotherapy
10
Paclitaxel
9
Dexamethasone
9
Nivolumab
8
Standard of Care
7
Oxaliplatin
7
Fluorouracil
7
Erlotinib Hydrochloride
7
apatinib
6
Interviews as Topic
6
Gemcitabine
6
Control Groups
6
Cisplatin
6
Therapeutics
5
Neoadjuvant Therapy
5
Mindfulness-Based Cognitive Therapy
5
Metformin
5
Injections
5
Everolimus
5
Docetaxel
5
Cyclophosphamide
5
Bevacizumab
5
sintilimab
4
atezolizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Neoplasms
×
Sodium Chloride
×
Clear all
NCT04741880
2021-07-30
ELSA
Instituto Nacional de Cancer, Brazil
Phase 2/3
Unknown
66 enrolled
NCT01427400
2016-07-29
Botox
University of British Columbia
Phase 4
Unknown
128 enrolled